Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer

NCT00740636 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Temozolomide
DRUG: Temozolomide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]